Cellular MicroRNAs 498 and 320d Regulate Herpes Simplex Virus 1 Induction of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Targeting RTA

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Yan, Qin ^a   Li, Wan ^a   Tang, Qiao ^a,b   Yao, Shuihong ^c   Lv, Zhigang ^a,d   Feng, Ninghan ^b   Ma, Xinting ^a   Bai, Zhiqiang ^a   Zeng, Yi ^e   Qin, Di ^a   Lu, Chun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c QUZHOU UNIVERSITY   (China)

^d Jiangsu Province Official Hospital   (China)

^e YOUJIANG MEDICAL COLLEGE FOR NATIONALITIES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 320D; MICRORNA 498; PROTEIN; REPLICATION AND TRANSCRIPTION ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; MICROARRAY ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS ACTIVATION; VIRUS CARCINOGENESIS; VIRUS REPLICATION;

3' UNTRANSLATED REGIONS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 1, HUMAN; HERPESVIRUS 8, HUMAN; HUMANS; MICRORNAS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 84873908103     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055832     Document Type: Article

References (69)

1. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865-1869.
2. Greene W, Kuhne K, Ye F, Chen J, Zhou F, et al. (2007) Molecular biology of KSHV in relation to AIDS-associated oncogenesis. Cancer Treat Res 133: 69-127.
3. Zeng Y, Zhang X, Huang Z, Cheng L, Yao S, et al. (2007) Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling. J Virol 81: 2401-2417.
4. Zhu X, Zhou F, Qin D, Zeng Y, Lv Z, et al. (2011) Human immunodeficiency virus type 1 induces lytic cycle replication of Kaposi's-sarcoma-associated herpesvirus: role of Ras/c-Raf/MEK1/2, PI3K/AKT, and NF-kappaB signaling pathways. J Mol Biol 410: 1035-1051.
5. Vieira J, O'Hearn P, Kimball L, Chandran B, Corey L, (2001) Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus. J Virol 75: 1378-1386.
6. Lu C, Zeng Y, Huang Z, Huang L, Qian C, et al. (2005) Human herpesvirus 6 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus. Am J Pathol 166: 173-183.
7. Tang Q, Qin D, Lv Z, Zhu X, Ma X, et al. (2012) Herpes simplex virus type 2 triggers reactivation of Kaposi's sarcoma-associated herpesvirus from latency and collaborates with HIV-1 Tat. PLoS One 7: e31652.
8. Varthakavi V, Smith RM, Deng H, Sun R, Spearman P, (2002) Human immunodeficiency virus type-1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus through induction of KSHV Rta. Virology 297: 270-280.
9. Qin D, Zeng Y, Qian C, Huang Z, Lv Z, et al. (2008) Induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1: involvement of IL-10 and IL-4. Cell Microbiol 10: 713-728.
10. Qin D, Feng N, Fan W, Ma X, Yan Q, et al. (2011) Activation of PI3K/AKT and ERK MAPK signal pathways is required for the induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1. BMC Microbiol 11: 240.
11. van Benthem BH, Spaargaren J, van Den Hoek JA, Merks J, Coutinho RA, et al. (2001) Prevalence and risk factors of HSV-1 and HSV-2 antibodies in European HIV infected women. Sex Transm Infect 77: 120-124.
12. Casper C, Wald A, Pauk J, Tabet SR, Corey L, et al. (2002) Correlates of prevalent and incident Kaposi's sarcoma-associated herpesvirus infection in men who have sex with men. J Infect Dis 185: 990-993.
13. Chen T, Hudnall SD, (2006) Anatomical mapping of human herpesvirus reservoirs of infection. Mod Pathol 19: 726-737.
14. Kumar N, McLean K, Inoue N, Moles DR, Scully C, et al. (2007) Human herpesvirus 8 genoprevalence in populations at disparate risks of Kaposi's sarcoma. J Med Virol 79: 52-59.
15. Lin SS, Chou MY, Ho CC, Kao CT, Tsai CH, et al. (2005) Study of the viral infections and cytokines associated with recurrent aphthous ulceration. Microbes Infect 7: 635-644.
16. Miller CS, Avdiushko SA, Kryscio RJ, Danaher RJ, Jacob RJ, (2005) Effect of prophylactic valacyclovir on the presence of human herpesvirus DNA in saliva of healthy individuals after dental treatment. J Clin Microbiol 43: 2173-2180.
17. Birek C, Ficarra G, (2006) The diagnosis and management of oral herpes simplex infection. Curr Infect Dis Rep 8: 181-188.
18. Harel L, Smetana Z, Prais D, Book M, Alkin M, et al. (2004) Presence of viremia in patients with primary herpetic gingivostomatitis. Clin Infect Dis 39: 636-640.
19. Holzinger D, Kuhn J, Ehlert K, Groll AH, (2010) HSV-1 viremia as a potential cause of febrile neutropenia in an immunocompromised child. J Pediatr Hematol Oncol 32: e19-21.
20. Berrington WR, Jerome KR, Cook L, Wald A, Corey L, et al. (2009) Clinical correlates of herpes simplex virus viremia among hospitalized adults. Clin Infect Dis 49: 1295-1301.
21. Boivin G, Malette B, Goyette N, (2009) Disseminated herpes simplex virus type 1 primary infection in a healthy individual. Can J Infect Dis Med Microbiol 20: 122-125.
22. Key NS, Vercellotti GM, Winkelmann JC, Moldow CF, Goodman JL, et al. (1990) Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proc Natl Acad Sci U S A 87: 7095-7099.
23. Lamontagne L, Jolicoeur P, (1994) Herpes simplex virus type 1 pathogenicity in mice expressed by lytic infection in pre-B and B cells. Clin Immunol Immunopathol 73: 38-44.
24. Scheglovitova ON, Romanov YA, Maksianina EV, Svintsitskaya VA, Pronin AG, (2002) Herpes simplex type I virus infected human vascular endothelial cells induce the production of anti-viral and proinflammatory factors by peripheral blood leukocytes in vitro. Russ J Immunol 7: 115-122.
25. Scheglovitova ON, Romanov YA, Maksianina EV, Kabaeva NV, Pronin AG, (2001) Herpes Simplex Type I Virus Infection of Cultured Human Vascular Endothelial Cells: Expression of Cell Adhesion Molecules and Induction of Interferon and Cytokine Production by Blood Mononuclear Cells. Russ J Immunol 6: 367-376.
26. Scheglovitova ON, Romanov YA, Maksianina EV, Samoilenko OV, Kabaeva NV, (2000) The Effect of Smooth Muscle Cells and Leukocytes on HSV-1 Reproduction in Cultured Human Endothelial Cells. Russ J Immunol 5: 133-140.
27. Cheng B, Martinez FP, Katano H, Tang Q, (2009) Evidence of inability of human cytomegalovirus to reactivate Kaposi's sarcoma-associated herpesvirus from latency in body cavity-based lymphocytes. J Clin Virol 46: 244-248.
28. Lukac DM, Kirshner JR, Ganem D, (1999) Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J Virol 73: 9348-9361.
29. Cai X, Lu S, Zhang Z, Gonzalez CM, Damania B, et al. (2005) Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci U S A 102: 5570-5575.
30. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
31. Samols MA, Hu J, Skalsky RL, Renne R, (2005) Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus. J Virol 79: 9301-9305.
32. Hansen A, Henderson S, Lagos D, Nikitenko L, Coulter E, et al. (2010) KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming. Genes Dev 24: 195-205.
33. Samols MA, Skalsky RL, Maldonado AM, Riva A, Lopez MC, et al. (2007) Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog 3: e65.
34. Liang D, Gao Y, Lin X, He Z, Zhao Q, et al. (2011) A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKKepsilon. Cell Res 21: 793-806.
35. Lin X, Liang D, He Z, Deng Q, Robertson ES, et al. (2011) miR-K12-7-5p encoded by Kaposi's sarcoma-associated herpesvirus stabilizes the latent state by targeting viral ORF50/RTA. PLoS One 6: e16224.
36. Lei X, Bai Z, Ye F, Xie J, Kim CG, et al. (2010) Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat Cell Biol 12: 193-199.
37. Gottwein E, Cullen BR, (2010) A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrest. J Virol 84: 5229-5237.
38. Skalsky RL, Samols MA, Plaisance KB, Boss IW, Riva A, et al. (2007) Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J Virol 81: 12836-12845.
39. Lu CC, Li Z, Chu CY, Feng J, Feng J, et al. (2010) MicroRNAs encoded by Kaposi's sarcoma-associated herpesvirus regulate viral life cycle. EMBO Rep 11: 784-790.
40. Umbach JL, Cullen BR, (2009) The role of RNAi and microRNAs in animal virus replication and antiviral immunity. Genes Dev 23: 1151-1164.
41. Zhang GL, Li YX, Zheng SQ, Liu M, Li X, et al. (2010) Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210. Antiviral Res 88: 169-175.
42. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P, (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309: 1577-1581.
43. Triboulet R, Mari B, Lin YL, Chable-Bessia C, Bennasser Y, et al. (2007) Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 315: 1579-1582.
44. Wang FZ, Weber F, Croce C, Liu CG, Liao X, et al. (2008) Human cytomegalovirus infection alters the expression of cellular microRNA species that affect its replication. J Virol 82: 9065-9074.
45. Zheng SQ, Li YX, Zhang Y, Li X, Tang H, (2011) MiR-101 regulates HSV-1 replication by targeting ATP5B. Antiviral Res 89: 219-226.
46. Ellis-Connell AL, Iempridee T, Xu I, Mertz JE, (2010) Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication. J Virol 84: 10329-10343.
47. Lagos D, Pollara G, Henderson S, Gratrix F, Fabani M, et al. (2010) miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nat Cell Biol 12: 513-519.
48. Umbach JL, Kramer MF, Jurak I, Karnowski HW, Coen DM, et al. (2008) MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 454: 780-783.
49. Tang S, Patel A, Krause PR, (2009) Novel less-abundant viral microRNAs encoded by herpes simplex virus 2 latency-associated transcript and their roles in regulating ICP34.5 and ICP0 mRNAs. J Virol 83: 1433-1442.
50. Murphy E, Vanicek J, Robins H, Shenk T, Levine AJ, (2008) Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: implications for latency. Proc Natl Acad Sci U S A 105: 5453-5458.
51. Bellare P, Ganem D, (2009) Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation. Cell Host Microbe 6: 570-575.
52. Lu F, Stedman W, Yousef M, Renne R, Lieberman PM, (2010) Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway. J Virol 84: 2697-2706.
53. Zhao JJ, Yang J, Lin J, Yao N, Zhu Y, et al. (2009) Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv Syst 25: 13-20.
54. Shen YL, Jiang YG, Greenlee AR, Zhou LL, Liu LH, (2009) MicroRNA expression profiles and miR-10a target in anti-benzo[a] pyrene-7, 8-diol-9, 10-epoxide-transformed human 16HBE cells. Biomed Environ Sci 22: 14-21.
55. Schepeler T, Reinert JT, Ostenfeld MS, Christensen LL, Silahtaroglu AN, et al. (2008) Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 68: 6416-6424.
56. Bronisz A, Godlewski J, Wallace JA, Merchant AS, Nowicki MO, et al. (2012) Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol 14: 159-167.
57. Ishida H, Tatsumi T, Hosui A, Nawa T, Kodama T, et al. (2011) Alterations in microRNA expression profile in HCV-infected hepatoma cells: involvement of miR-491 in regulation of HCV replication via the PI3 kinase/Akt pathway. Biochem Biophys Res Commun 412: 92-97.
58. Zhang H, Li W, Nan F, Ren F, Wang H, et al. (2011) MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line. Biochem Biophys Res Commun 404: 273-278.
59. Duan H, Jiang Y, Zhang H, Wu Y, (2010) MiR-320 and miR-494 affect cell cycles of primary murine bronchial epithelial cells exposed to benzo[a]pyrene. Toxicol In Vitro 24: 928-935.
60. Schaar DG, Medina DJ, Moore DF, Strair RK, Ting Y, (2009) miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation. Exp Hematol 37: 245-255.
61. Wang XH, Qian RZ, Zhang W, Chen SF, Jin HM, et al. (2009) MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats. Clin Exp Pharmacol Physiol 36: 181-188.
62. Chen L, Yan HX, Yang W, Hu L, Yu LX, et al. (2009) The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma. J Hepatol 50: 358-369.
63. Li J, Wan Y, Guo Q, Zou L, Zhang J, et al. (2010) Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis. Arthritis Res Ther 12: R81.
64. Shaoqing Y, Ruxin Z, Guojun L, Zhiqiang Y, Hua H, et al. (2011) Microarray analysis of differentially expressed microRNAs in allergic rhinitis. Am J Rhinol Allergy 25: e242-246.
65. Shang Y, Yang X, Zhang R, Zou H, Zhao R, (2012) Low amino acids affect expression of 11beta-HSD2 in BeWo cells through leptin-activated JAK-STAT and MAPK pathways. Amino Acids 42: 1879-1887.
66. Ye F, Zhou F, Bedolla RG, Jones T, Lei X, et al. (2011) Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latency. PLoS Pathog 7: e1002054.
67. Xu D, Coleman T, Zhang J, Fagot A, Kotalik C, et al. (2007) Epstein-Barr virus inhibits Kaposi's sarcoma-associated herpesvirus lytic replication in primary effusion lymphomas. J Virol 81: 6068-6078.
68. Gusev Y, (2008) Computational methods for analysis of cellular functions and pathways collectively targeted by differentially expressed microRNA. Methods 44: 61-72.
69. Han ZB, Zhong L, Teng MJ, Fan JW, Tang HM, et al. (2012) Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation. Mol Oncol 6: 445-457.